FAQ on Oragenics Inc.'s Presentation at the Centurion One Capital 2nd Annual Bahamas Summit

What is Oragenics Inc. presenting at the Centurion One Capital 2nd Annual Bahamas Summit?

Oragenics Inc. will deliver a corporate presentation and participate in a Q&A session, showcasing its developments in nasal delivery of pharmaceutical medications for neurology and infectious diseases, including treatments for mild traumatic brain injury and Niemann Pick Disease Type C.

When and where is the Centurion One Capital 2nd Annual Bahamas Summit taking place?

The summit is scheduled for October 22-23, 2024, at the Rosewood Baha Mar Hotel in Nassau, Bahamas, with Oragenics’ presentation set for 1:20 p.m. ET on October 22.

Who will represent Oragenics Inc. at the summit?

President Michael Redmond will represent Oragenics Inc., delivering the corporate presentation and engaging in the Q&A session.

What are the key focus areas of Oragenics Inc.?

Oragenics Inc. specializes in the nasal delivery of pharmaceutical medications, focusing on neurology and infectious diseases, with drug candidates for mild traumatic brain injury and Niemann Pick Disease Type C, among others.

How can I learn more about Oragenics Inc.?

For more information, visit Oragenics’ website at www.Oragenics.com or check the latest news and updates at https://ibn.fm/OGEN.

What is the significance of Oragenics Inc.’s participation in the summit?

Oragenics’ participation highlights its commitment to advancing treatments for brain-related health issues and infectious diseases, offering investors and the public insights into its innovative approaches and developments.

Where can I view the full press release about Oragenics Inc.’s presentation?

The full press release can be viewed at https://ibn.fm/ybeTj.

InvestorWire is a specialized communications platform that provides press release syndication and other corporate communications solutions, part of the Dynamic Brand Portfolio at IBN, which disseminates Oragenics Inc.’s news and updates.

Summary